Health Condition 1: null- Osteoarthritis
Conditions
Interventions
Intervention1: Arthronat: 1500 mg (500mg X 3) 2 times in a day for 4 weeks
Control Intervention1: Placebo: 3 capsules 2 times in a day for 4 weeks
Sponsors
Rowtasha
Eligibility
Inclusion criteria
Inclusion criteria: A previously diagnosed (atleast 3 months prior to the screening visit) case of osteoarthritis of hip, knees based on the ACR Clinical Classification criteria for osteoarthritis A previously diagnosed (atleast 3 months prior to screening visit) case on shoulders, neck and wrists based on the clinical and radiographic findings.
Exclusion criteria
Exclusion criteria: Subject with history of disease which may involve the index joint including but not limited to rheumatoid arthritis Any inflammatory joint disease Metabolic bone disease (gout, pseudo gout etc) Bone tumours Joint infections (reactive arthritis, septic arthritis) Avascular necrosis (especially of neck of femur) Neuropathic disorders etc.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Change in the pain scores as evaluated by Visual Analogue Scale (VAS) at end of 1 week as compared to Baseline (Day 0 / Visit 2) Improvement (change) in mobility at the end of Week 1 as compared to Baseline (day 0 / Visit 2) evaluated by change in the WOMAC sub-scales of Stiffness and Physical function.Timepoint: 1 Week | — |
Secondary
| Measure | Time frame |
|---|---|
| Change in the pain scores as evaluated by VAS at end of 2, 3 and 4 weeks as compared to Baseline (Day 0 / Visit 2)Timepoint: week 2, 3 and 4 | — |
Countries
India
Contacts
Public ContactKarthik C
Outcome results
None listed